Quadrant Capital Group’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.5K Hold
677
﹤0.01% 1846
2025
Q4
$26.2K Buy
677
+175
+35% +$6.67K ﹤0.01% 1901
2025
Q3
$17.7K Buy
+502
New +$18.2K ﹤0.01% 1991
2025
Q2
Sell
-474
Closed -$14.8K 2342
2025
Q1
$14.8K Buy
474
+89
+23% +$2.82K ﹤0.01% 2128
2024
Q4
$9.82K Sell
385
-775
-67% -$20.6K ﹤0.01% 2131
2024
Q3
$32.8K Sell
1,160
-618
-35% -$17.1K ﹤0.01% 1677
2024
Q2
$46.9K Sell
1,778
-2,210
-55% -$61.3K ﹤0.01% 1438
2024
Q1
$121K Buy
3,988
+501
+14% +$14.8K 0.01% 902
2023
Q4
$98K Buy
3,487
+2,606
+296% +$71.6K 0.01% 1013
2023
Q3
$23.9K Buy
881
+652
+285% +$19.4K ﹤0.01% 1630
2023
Q2
$7.04K Sell
229
-290
-56% -$9.82K ﹤0.01% 2117
2023
Q1
$18.7K Buy
519
+283
+120% +$10.5K ﹤0.01% 1735
2022
Q4
$9.33K Sell
236
-13
-5% -$543 ﹤0.01% 1982
2022
Q3
$10K Sell
249
-118
-32% -$5.04K ﹤0.01% 1898
2022
Q2
$15K Sell
367
-7
-2% -$287 ﹤0.01% 1446
2022
Q1
$14K Buy
374
+122
+48% +$4.79K ﹤0.01% 1507
2021
Q4
$10K Buy
252
+202
+404% +$7.85K ﹤0.01% 1638
2021
Q3
$2K Sell
50
-217
-81% -$8.43K ﹤0.01% 2187
2021
Q2
$11K Buy
267
+264
+8,800% +$11.2K ﹤0.01% 1517
2021
Q1
$0 Hold
3
﹤0.01% 2447
2020
Q4
$0 Buy
+3
New +$127 ﹤0.01% 2365

Other funds holding RPRX